Switzerland-Slovenia Bilateral Trade Analysis 2023

Complete trade statistics: $25.35B total volume โ€ขSwitzerland deficit: $2.80B

Switzerland โ†’ Slovenia

$11.27B

Exports (2023)

Slovenia โ†’ Switzerland

$14.08B

Imports (2023)

Trade Balance

$2.80B

Deficit for Switzerland

Total Trade

$25.35B

Combined Volume

Trade Flow Visualization

Direct trade relationship between Switzerland and Slovenia. Green line shows exports from Switzerland, red line shows imports.

Detailed Product Trade Analysis

Comprehensive breakdown of trade flows by product category, revealing the specialized nature of the Switzerland-Slovenia commercial relationship and competitive positioning in global markets.

Switzerland โ†’ Slovenia Exports

$11.27B
2023 Total

Export Market Intelligence

Product Diversity:
Highly Diversified
Market Share:
49.4% top product
1Medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale
$5.57B
49.4% of exports
2Heterocyclic compounds: with nitrogen hetero-atom(s) only, containing an unfused pyrazole ring (whether or not hydrogenated) in the structure, other than henazone (antipyrin) and its derivatives
$1.76B
15.6% of exports
3Heterocyclic compounds: n.e.c. in headings no. 2933
$1.01B
8.9% of exports
4Sulphonamides: n.e.c. in heading no. 2935
$973.34M
8.6% of exports
5Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, (other than malonylurea and its derivatives, loprazolam, mecloqualone, methaqualone, zipeprol, and salts thereof) n.e.c. in 2933.5
$834.77M
7.4% of exports
6Blood, human or animal, antisera, other blood fractions and immunological products: immunological products, put up in measured doses or in forms or packings for retail sale
$450.05M
4.0% of exports
7Medicaments: containing antibiotics (other than penicillins, streptomycins or their derivatives), for therapeutic or prophylactic uses, packaged for retail sale
$253.90M
2.3% of exports
8Metals: gold, non-monetary, unwrought (but not powder)
$50.03M
0.4% of exports
9Metals: gold, semi-manufactured
$30.09M
0.3% of exports
10Wrist-watches: whether or not incorporating a stop-watch facility, with automatic winding
$20.51M
0.2% of exports

๐ŸŽฏ Strategic Export Focus

Switzerland's export portfolio to Slovenia demonstrates strong diversification across multiple sectors, with medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale representing a key competitive advantage in this bilateral market.

Slovenia โ†’ Switzerland Imports

$14.08B
2023 Total

Import Dependency Profile

Supply Diversity:
Well Diversified
Critical Imports:
91.4% concentration
1Medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale
$12.87B
91.4% of imports
2Heterocyclic compounds: n.e.c. in headings no. 2933
$316.09M
2.2% of imports
3Blood, human or animal, antisera, other blood fractions and immunological products: immunological products, put up in measured doses or in forms or packings for retail sale
$148.35M
1.1% of imports
4Medicaments: containing antibiotics (other than penicillins, streptomycins or their derivatives), for therapeutic or prophylactic uses, packaged for retail sale
$56.12M
0.4% of imports
5Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, (other than malonylurea and its derivatives, loprazolam, mecloqualone, methaqualone, zipeprol, and salts thereof) n.e.c. in 2933.5
$46.67M
0.3% of imports
6Medicaments: containing alkaloids or their derivatives: other than ephedrine, pseudoephedrine (INN) or norephedrine or their salts: for therapeutic or prophylactic uses, packaged for retail sale
$41.16M
0.3% of imports
7Medicaments: (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale)
$28.58M
0.2% of imports
8Buildings: prefabricated, not of wood
$25.76M
0.2% of imports
9Vehicles: with only compression-ignition internal combustion piston engine (diesel or semi-diesel), cylinder capacity over 1500 but not over 2500cc
$22.63M
0.2% of imports
10Meat and edible offal: of fowls of the species Gallus domesticus, cuts and offal, fresh or chilled
$15.67M
0.1% of imports

๐Ÿ“ฆ Import Strategy Analysis

Switzerland's import pattern from Slovenia reveals strategic sourcingin medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale, highlighting complementary economic structures and potential supply chain optimization opportunities.

Competitive Trade Position Analysis

๐Ÿ†

Market Leadership

Switzerland demonstrates competitive strength in exportingmedicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale to Slovenia, leveraging comparative advantages.

Export Leader in 20+ Categories
๐Ÿ”„

Trade Complementarity

The bilateral relationship showsstrongcomplementarity, with each country specializing in different sectors.

Highly Balanced
๐Ÿ“ˆ

Growth Potential

The $25.35B trade volume indicates substantial economic integration with room for expansion in emerging sectors.

Major Partnership

Executive Summary: Switzerland-Slovenia Trade Relationship

Key Trade Highlights 2023

  • Total Trade Volume: $25.35 billionrepresenting a significant bilateral economic relationship
  • Trade Balance: Switzerland maintains a deficit of $2.80 billion
  • Export Focus: Switzerland's primary exports include medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale, heterocyclic compounds: with nitrogen hetero-atom(s) only, containing an unfused pyrazole ring (whether or not hydrogenated) in the structure, other than henazone (antipyrin) and its derivatives, heterocyclic compounds: n.e.c. in headings no. 2933
  • Import Dependencies: Key imports from Slovenia include medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale, heterocyclic compounds: n.e.c. in headings no. 2933, blood, human or animal, antisera, other blood fractions and immunological products: immunological products, put up in measured doses or in forms or packings for retail sale

Strategic Trade Indicators

Trade IntensityHigh
Export DiversificationDiversified
Trade Balance HealthBalanced

๐Ÿ“ˆ Market Position: This bilateral trade relationship represents a significant global trade partnerships, with complementary economic strengths driving sustained commercial exchange.

Historical Trade Analysis & Economic Context

Trade Evolution Timeline

2019-2023: Recent Trends

Current trade volume of $25.35B represents the culmination of evolving bilateral commercial relationships, influenced by global supply chain shifts and changing economic priorities.

2015-2019: Growth Period

Sustained expansion in bilateral trade driven by complementary economic structures, with Switzerland leveraging its comparative advantages in medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale.

2010-2015: Foundation Building

Establishment of modern trade frameworks and reduction of barriers, facilitating increased commercial exchange and investment flows between the two economies.

Pre-2010: Early Development

Initial stages of bilateral trade relationship development, with focus on traditional export-import patterns and gradual market integration.

Key Economic Drivers

1

Comparative Advantage

Switzerland's specialization in medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail salecomplements Slovenia's demand patterns, creating natural trade synergies.

2

Supply Chain Integration

Deep integration in global value chains has strengthened bilateral linkages, particularly in medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale.

3

Market Access & Trade Policy

Favorable trade agreements and market access conditions have facilitated the growth of this $25.35B bilateral relationship.

Trade Pattern Insights

Trade ComplementarityAsymmetric
Seasonal VariationsModerate
Product ConcentrationLow
Market DependencyModerate
๐Ÿ”ฎ

Trade Relationship Outlook

The $25.35B bilateral trade volume positions this relationship for continued growth, supported by technological advancement, evolving consumer preferences, and strengthening economic ties. Key opportunities lie in expanding cooperation in emerging sectors while managing potential supply chain vulnerabilities.

Economic Impact & Strategic Outlook

Economic Impact Assessment

๐Ÿ’ฐ

Trade Volume Impact

The $25.35 billion bilateral trade volume represents a significant economic factorfor both economies.

Economic Significance: High
๐Ÿญ

Industrial Integration

Trade flows in medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale and medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale demonstrate deep industrial linkages and supply chain integration.

Supply Chain Integration: Diversified
โš–๏ธ

Trade Balance Effects

Switzerland's trade deficit of $2.80 billion impacts its overall economic position in this bilateral relationship.

Balance Impact: Well Balanced

Strategic Future Outlook

๐Ÿš€Growth Opportunities

Emerging Sectors
Technology transfer and innovation cooperation in heterocyclic compounds: with nitrogen hetero-atom(s) only, containing an unfused pyrazole ring (whether or not hydrogenated) in the structure, other than henazone (antipyrin) and its derivatives present expansion opportunities.
Market Diversification
Beyond current focus on medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale, new product categories offer potential for trade expansion.

โš ๏ธRisk Factors

Supply Chain Vulnerabilities
Moderate concentration in key sectors requires monitoring
Market Competition
Global competition in medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale may affect future market positioning.

๐ŸŽฏStrategic Recommendations

  • Strengthen cooperation in high-value sectors beyond current trade patterns
  • Develop alternative supply chains to reduce dependency risks
  • Explore joint ventures in emerging technology sectors
  • Enhance trade facilitation and reduce transaction costs

Market Position & Competitive Summary

The bilateral trade relationship between Switzerland and Slovenia represents a total trade volume of $25.35 billion in 2023. This partnership demonstrates an unfavorable trade balance for Switzerland, with imports exceeding exportsby $2.80 billion.

Export Strengths

Switzerland's exports to Slovenia total $11.27 billion, with competitive advantages in medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale, representing $5.57B or49.4% of bilateral exports.

Import Dependencies

Imports from Slovenia amount to $14.08 billion, highlighting economic interdependence in medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale, with Medicaments: consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale comprising91.4% of total imports.

The trade relationship reflects broader economic patterns and comparative advantages. The trade deficit indicates Switzerland's strategic sourcing from Slovenia. This partnership is characterized by complementary trade flows, with each country specializing in different product categories based on their respective economic strengths, industrial capabilities, and position in global value chains.

Download Bilateral Trade Data

Access detailed trade data between Switzerland and Slovenia in multiple formats.

Data Source: CEPII BACI (Base pour l'Analyse du Commerce International) โ€ข Last Updated: January 2025 โ€ข Coverage: 1995-2023